Position in PTCT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$141,332,210
-$71,497,759 QoQ
Shares Held
2,074,449
-26.0% QoQ
Ownership
25.0%
of shares outstanding
% of Portfolio
4.70%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Derivatives in PTCT
reported options exposure · as of Mar 31, 2026CallValue
$26,570,700
CallShares
390,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026ARMISTICE CAPITAL, LLC holds $1,383,311,336 across 53 Biotechnology names. PTCT ranks #2 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TVTX |
Travere Therapeutics, Inc.
|
4,897,417 | $145,502,259 | |
| 2 | PTCT |
Ptc Therapeutics, Inc.
This page
|
2,074,449 | $141,332,210 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
264,583 | $138,501,263 | |
| 4 | AGIO |
Agios Pharmaceuticals, Inc.
|
2,716,000 | $91,882,280 | |
| 5 | IMVT |
Immunovant, Inc.
|
3,564,916 | $88,552,513 | |
| 6 | INCY |
Incyte Corp
|
656,817 | $61,819,616 | |
| 7 | DYN |
Dyne Therapeutics, Inc.
|
3,175,110 | $57,564,744 | |
| 8 | CYTK |
Cytokinetics Inc
|
764,538 | $50,390,699 |
All Filings in PTCT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $26,570,700 | 390,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $141,332,210 | 2,074,449 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $212,829,969 | 2,801,869 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $201,126,182 | 3,277,272 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $231,280,061 | 4,735,464 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $276,959,599 | 5,434,843 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $287,902,920 | 6,378,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $268,414,715 | 7,234,898 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $212,904,901 | 6,962,227 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $196,764,760 | 6,764,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $189,171,840 | 6,864,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $137,821,500 | 6,150,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $131,608,120 | 3,236,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $141,638,560 | 2,924,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $129,625,320 | 3,396,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $145,580,000 | 2,900,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $132,037,760 | 3,296,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $113,273,160 | 3,036,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $36,528,371 | 917,107 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $96,597,160 | 2,596,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $88,428,840 | 2,092,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $66,100,600 | 1,396,000 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $43,697,480 | 716,000 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $33,847,000 | 724,000 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $25,370,000 | 500,000 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $26,766,000 | 600,000 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||